Bio-Techne (TECH) Operating Income Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.93% |
| Dec 31, 2025 | 1.32% |
| Sep 30, 2025 | -0.59% |
| Jun 30, 2025 | -21.12% |
| Mar 31, 2025 | -4.13% |
| Dec 31, 2024 | 5.09% |
| Sep 30, 2024 | 3.71% |
| Jun 30, 2024 | 1.16% |
| Mar 31, 2024 | 8.73% |
| Dec 31, 2023 | 2.49% |
| Sep 30, 2023 | 16.74% |
| Jun 30, 2023 | 17.11% |
| Mar 31, 2023 | 13.24% |
| Dec 31, 2022 | 22.97% |
| Sep 30, 2022 | 16.69% |
| Jun 30, 2022 | 15.01% |
| Mar 31, 2022 | 21.97% |
| Dec 31, 2021 | 28.38% |
| Sep 30, 2021 | 16.74% |
| Jun 30, 2021 | 11.38% |
| Mar 31, 2021 | 9.53% |
| Dec 31, 2020 | 7.20% |
| Sep 30, 2020 | 9.61% |
| Jun 30, 2020 | 0.79% |
| Mar 31, 2020 | 3.92% |
| Dec 31, 2019 | 1.36% |
| Sep 30, 2019 | -1.10% |
| Jun 30, 2019 | 2.18% |
| Mar 31, 2019 | -0.74% |
| Dec 31, 2018 | -1.23% |
| Sep 30, 2018 | -8.14% |
| Jun 30, 2018 | 21.86% |
| Mar 31, 2018 | -0.40% |
| Dec 31, 2017 | -8.13% |
| Sep 30, 2017 | -7.19% |
| Jun 30, 2017 | -0.58% |
| Mar 31, 2017 | -6.29% |
| Dec 31, 2016 | -13.85% |
| Sep 30, 2016 | -6.57% |
| Jun 30, 2016 | -1.25% |
| Mar 31, 2016 | -0.55% |
| Dec 31, 2015 | -0.72% |
| Sep 30, 2015 | -4.16% |
| Jun 30, 2015 | 21.09% |
| Mar 31, 2015 | -1.09% |
| Dec 31, 2014 | -1.10% |
| Sep 30, 2014 | -2.12% |